BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 215 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2023. The put-call ratio across all filers is 2.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $11,660,590 | +11.6% | 184,503 | -20.5% | 0.36% | +12.9% |
| Q1 2023 | $10,447,533 | +6.1% | 232,219 | +3.3% | 0.32% | +5.6% |
| Q4 2022 | $9,849,101 | +3.7% | 224,814 | +55.9% | 0.30% | -2.9% |
| Q3 2022 | $9,500,000 | +81.5% | 144,177 | +39.1% | 0.31% | +73.2% |
| Q2 2022 | $5,235,000 | -47.7% | 103,646 | -33.8% | 0.18% | -27.8% |
| Q1 2022 | $10,007,000 | +84.2% | 156,646 | +208.8% | 0.25% | +121.4% |
| Q4 2021 | $5,433,000 | +0.1% | 50,725 | -3.9% | 0.11% | +8.7% |
| Q3 2021 | $5,428,000 | -0.9% | 52,797 | -15.2% | 0.10% | +1.0% |
| Q2 2021 | $5,478,000 | -4.4% | 62,278 | +5.7% | 0.10% | -15.7% |
| Q1 2021 | $5,728,000 | -47.8% | 58,907 | -39.8% | 0.12% | -50.8% |
| Q4 2020 | $10,966,000 | -8.0% | 97,782 | -23.9% | 0.25% | -39.1% |
| Q3 2020 | $11,917,000 | +38.0% | 128,559 | +16.1% | 0.40% | +29.5% |
| Q2 2020 | $8,637,000 | – | 110,726 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 448,987 | $28,375,978 | 15.72% |
| DAFNA Capital Management LLC | 251,521 | $15,896,127 | 4.35% |
| Casdin Capital, LLC | 620,000 | $39,184,000 | 3.42% |
| Rock Springs Capital Management LP | 2,186,672 | $138,197,670 | 3.29% |
| EcoR1 Capital, LLC | 1,798,300 | $113,652,560 | 2.78% |
| Novo Holdings A/S | 448,804 | $28,364,413 | 2.19% |
| ORACLE INVESTMENT MANAGEMENT INC | 41,377 | $2,615,026 | 1.93% |
| SECTORAL ASSET MANAGEMENT INC | 136,837 | $8,648,098 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 413,327 | $26,122,266 | 1.42% |
| EMERALD ADVISERS, LLC | 496,053 | $31,350,550 | 1.37% |